Literature DB >> 8916168

Lyme neuroborreliosis masquerading as a brainstem tumor in a 15-year-old.

R G Curless1, N J Schatz, B C Bowen, Z Rodriguez, A Ruiz.   

Abstract

A 15-year-old boy had onset of unilateral facial weakness. A few days later, he experienced mild vertigo, double vision, and headache. Examination confirmed a peripheral right seventh nerve weakness in addition to an internuclear ophthalmoplegia. The neurologic features suggested a pontine glioma. A T2-weighted MRI scan revealed demyelinating lesions in the pons and in several areas of the cerebrum, including the periventricular region. Subsequent history revealed that he had been diagnosed with Lyme arthritis 7 years earlier while living in Connecticut. The radiographic studies favored a diagnosis of multiple sclerosis. However, studies of blood and cerebrospinal fluid established a diagnosis of Lyme neuroborreliosis.

Entities:  

Mesh:

Year:  1996        PMID: 8916168     DOI: 10.1016/s0887-8994(96)00172-5

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  4 in total

1.  Internuclear ophthalmoplegia as the first sign of neuroborreliosis.

Authors:  Willem J Hardon; Hans J J A Bernsen; Jose van Nouhuys-Leenders; Bert Mulder
Journal:  J Neurol       Date:  2002-08       Impact factor: 4.849

2.  Lyme disease of the brainstem.

Authors:  Peter Kalina; Andrew Decker; Ezriel Kornel; John J Halperin
Journal:  Neuroradiology       Date:  2005-09-13       Impact factor: 2.804

3.  Neuroborreliosis Mimicking Leptomeningeal Carcinomatosis in a Patient With Breast Cancer: A Case Report.

Authors:  Stefanie Fischer; Johannes Weber; Isabelle Senn-Schönenberger; Thomas Cerny; Thomas Hundsberger
Journal:  J Investig Med High Impact Case Rep       Date:  2014-03-28

4.  Vertigo and Severe Balance Instability as Symptoms of Lyme Disease-Literature Review and Case Report.

Authors:  Magdalena Jozefowicz-Korczynska; Ewa Zamyslowska-Szmytke; Anna Piekarska; Oskar Rosiak
Journal:  Front Neurol       Date:  2019-11-12       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.